A great way to get exposure to crypto in your stock brokerage account is to look for great companies that do business within the crypto space. One such company is Bitcoin Group SE, a german holding company that owns several german crypto companies, among the Bitcoin.de, a well known crypto exchange. It is fascinating to see how it finally caught fire and...
Oil price increasing after OPEX production cut
First Key level to watch is around 68-70
* Retail distribution agreement for Nordics and UK with Norgesgruppen * Successfull private offering on NOK 55 securing a good cash position to see company through to positive cash flow * Enthustiastic Danish coverage of successfull animal experiments for antiviral inhalation treatment "Possible game changer, says University of Copenhagen" Comes on top of...
Watch the continues weakening of TVC:DXY
100 NOK the last major resistance in the chart. Ready to break out from Triangle formation. Nice EMA 20 / 100 Bounce Strong Analyst BUY consensus from DNB Markets, ABG, Norne etc.
Note that information about the third study is still expected before year end. Ultimovacs ASA – Initiates FOCUS Phase II Trial for Universal Cancer Vaccine, UV1, in Head and Neck Cancer Patients Receiving Pembrolizumab Oslo, 22 December 2020: Ultimovacs ASA (“Ultimovacs”, ticker ULTI), today announced the initiation of FOCUS, a Phase II randomized clinical...
Following on strong momentum after Novartis deal, Sangamo Therapeutics with strong open that looks set to breakout the stock from a long sustained downtrend
ABG Sundal Collier: Photocure - Q3: a solid stepping stone towards expansion Q3 results due 10 November US recovery and EU commercialisation in the spotlight Tweaking near term ests. – DCF TP up to NOK 130 (125)
OSE35 HEALTH CARE_GI Oslo Børs is migrating to Euronext trading system, which has mixed up a few of the tickers for the indexes. As we can see, Healthcare is back in rally mode after a sharp recent pullback
Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and genome regulation.
Vaccibody reports promising preclinical data with a second-generation COVID-19 vaccine and announces its infectious disease strategy ● Vaccibody demonstrates promising pre-clinical data with its second-generation COVID-19 vaccine candidate, VB10.COV2 ● VB10.COV2 induces rapid, strong and long-lasting neutralizing antibodies and multifunctional, dominant CD8+ T...
Episurf submitted a very strong newsflow ahead of its capital markets day and the stock market reacted very positively to this. Some cooling off is to be expected after such a strong move, but the stock is pulling back in a very calm manner and looking to establish support on top of previous highs from January. Watch for reduced selling pressure above the 2 SEK line.
After underperforming related to Bitcoin the $ADE stock is finally picking up speed, punching through the first major resistance.
ONCOS-102 is one of the most promising oncolytic viruses with >200 patients treated. Targovax stock has been under pressure for years after equity offerings at fairly low pricing, but has been making a strong move recently, quite without many investors taking notice. Norwegian Biotech especially in the field of cancer immunotherapy may be ready for a new round of...
SoftOx Solutions AS is a Scandinavian medtech company, founded in 2012, listed at Euronext Growth with new ticker OSL:SOFTX . After years of research and product development with leading Nordic research institutions, SoftOx has developed a non-toxic and highly efficient antiseptic technology, which eradicates and prevents biofilm infections and is fully...
Also recent Bank of America BUY with price target 30 NOK
"En av børsens fineste aksjer"